1[1]Sarzi-Puttini P,Santandrea S,Boccassini L,et al.The role of NSAIDs in psoriatic arthritis:evidence from a controlled study with nimesulide[J].Clin Exp Rheumatol,2001,19 (1 Supp 1 22):S17.
2[2]Clark DW,Coulter DM.Psoriasis associated with rofecoxib[J].Arch Dermatol,2003,139:1223.
3[3]Pipitone N,Kingsley GH,Manzo A,et al.Current concepts and new developments in the treatment of psoriatic arthritis[J].Rheumatology (Oxford),2003,42:1138.
4[4]Clegg DO,Reda DJ,Abdellatif M.Comparison of sulfasalazine and placebo for the treatment of axial and peripheral articular manifestations of the seronegative spondylarthropathies:a department of veterans affairs cooperative study[J].Arthritis Rheum,1999,42:2325.
5[5]Raffayova H,Rovensky J,Malis F.Treatment with cyclosporin in patients with psoriatic arthritis:results of clinical assessment[J].Int J Clin Pharmacol Res,2000,20:1.
6[6]Macchioni P,Boiardi L,Cremonesi T,et al.The relationship between serum-soluble interleukin-2 receptor and radiological evolution in psoriatic arthritis patients treated with cyclosporin-A[J].Rheumatol Int,1998,18:27.
7[7]Scarpa R,Manguso F,Oriente P,et al.Leflunomide in psoriatic polyarthritis:an Italian pilot study[J].Arthritis Rheum,2001,44:S92.
8[8]Liang GC,Barr WG.Long term follow up of the use of leflunomide in recalcitrant psoriatic arthritis and psoriasis[J].Arthritis Rheum,2001,44:S121.
9[9]Cuchacovich M,Soto L.Lefiunomide decreases joint erosions and induces reparative changes in a patient with psoriatic arthritis[J].Ann Rheum Dis,2002,61:942
10[10]Kaltwasser JP,Nash P,Gladman D,et al.Treatment of psoriatic arthritis study group.Efficacy and safety of leflunomide in the treatment of psoriatic arthritis and psoriasis:a multinational,double blind,randomized,placebo-controlled clinical trial[J].Arthritis Rheum,2004,50:1939.
4Ujfalussy I,Koo E.Measurement of disease activity in psoriatic arthritis.Extended report.Z Rheumatol,2003,62:60-65.
5Kaltwassor JP,Nash P,Gladman D,et al.Efficacy and safety of leflunomide in the treatment of psoriatic arthritis and psoriasis:a multinational,double-blind,randomized,placebo-controlled clinical trial.Arthritis Rheum,2004,50:1939-1950.
6Nash P,Thaci D,Behrenz F,et al.Leflunomide improves psoriasis in patients with psoriatic arthritis:an in-depth analysis of data from the TOPAS study.Dermatology,2006,212:238-249.
7Pipitone N,Kingsley GH,Manso A,et al.Current concepts and new developments in the treatment of psoriatic arthritis.Rheumatology (Oxford),2003,42:1138-1148.
8Scarpa R,Manguso F,Oriente A,et al.Leflunomide in psoriatic polyarthritis.J Clin Rheumatol,2002,8:286-287.
9Cuchacovich M,Soto L.Leflunomide decreases joint erosions and induces reparative changes in a patient with psoriatic arthritis.Ann Rheum Dis,2002,61:942-943.
10Strand V,Cohen S,Schiff M,et al.Treatment of active rheumatoid arthritis with leflunomide compared with placebo and methotrexate.Leflunomide Rheumatoid Arthritis Investigators Group.Arch Intern Med,1999,159:2542-2550.
